San Ramon, CA, United States of America

Xin Chen

This inventor holds 20 USPTO granted patents and 8 published patent applications and 6 EPO patents, primarily in Diabetes Treatment. Top assignees: Metabolex, Inc., Cymabay Therapeutics, Inc.. Active years: 2006-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xin Chen. Retrieved from https://idiyas.com/inventor/xin-chen-lwub07gx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 

% Patents Active = 35.0

 

Average Co-Inventor Count = 8.1

ph-index = 6

Forward Citations = 104(Granted Patents)


Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Agonists
GPR120 Receptor
Diabetes Treatment
Metabolic Disorders
Bicyclic Agonists
N-Linked Agonists
Pharmaceutical Compositions
Thiazoles
20 patents (USPTO):Explore Patents

Title: **Innovations by Inventor Xin Chen in Diabetes Treatment**

Introduction

Xin Chen is a prominent inventor based in San Ramon, CA. With an impressive portfolio of 20 patents, he has significantly contributed to the field of pharmaceuticals, particularly in the treatment of diabetes and metabolic disorders. His innovative work focuses on developing novel compounds that offer new hope for patients dealing with chronic health issues.

Latest Patents

Among his latest patents are groundbreaking inventions related to heterocyclic receptor agonists aimed at treating diabetes and other metabolic disorders. These patents detail compounds and methods specifically designed to address Type II diabetes and various diseases linked with poor glycemic control. Notably, the compounds developed through his research are orally active, enhancing their practicality and usability in medical treatment.

Career Highlights

Throughout his career, Xin Chen has had the opportunity to work with several esteemed organizations. Notably, he has been associated with Metabolex, Inc. and Cymabay Therapeutics, Inc., where he collaborated on advancing innovative treatments and therapies. His contributions have been pivotal in driving research forward in his field.

Collaborations

In his journey, Xin Chen has collaborated with notable colleagues such as Jingyuan Ma and Imad Nashashibi. These partnerships have enriched his research and development efforts, fostering a collaborative environment that is essential for significant scientific advancements.

Conclusion

Xin Chen's impressive portfolio of patents and his commitment to innovation in diabetes treatment highlights his important role as an inventor. His ongoing work continues to pave the way for new medical solutions, demonstrating the potential of scientific research to transform healthcare and improve the quality of life for individuals affected by diabetes and metabolic disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…